Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileAlan M Garber, M.D., Ph.D.

TitleMallinckrodt Professor of Health Care Policy
InstitutionHarvard University
DepartmentHealth Care Policy
AddressHarvard, Office of the Provost
Massachusetts Hall
Harvard Yard
Cambridge MA 02138
Phone617/732-6330
vCardDownload vCard (login for email)
Other Positions
TitleProfessor of Economics
InstitutionFaculty of Arts & Sciences
DepartmentEconomics

TitleProfessor of Public Policy
InstitutionJohn F. Kennedy School of Government
DepartmentFaculty Members

TitleProvost
InstitutionHarvard University
DepartmentProvost

TitleMember of the Board of Syndics of Harvard University Press
InstitutionOther
DepartmentHUP - Director Board Members

TitleProfessor, in the Dept. of Health Policy and Management
InstitutionHarvard T.H. Chan School of Public Health
DepartmentHealth Policy and Management


Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
R37AG036791     (GARBER, ALAN)Apr 1, 2011 - Dec 31, 2016
NIH/NIA
Estimating the Potential Medicare Savings from Comparative Effectiveness Research
Role: Principal Investigator

RC4AG039036     (GARBER, ALAN)Sep 30, 2010 - Aug 31, 2013
NIH/NIA
The Science of Medicare Reform
Role: Principal Investigator

P30AG024957     (GOLDSTEIN, MARY K.)Sep 30, 2004 - Aug 31, 2014
NIH/NIA
Center on Advancing Decision Making in Aging
Role: Co-Principal Investigator

D43TW005817     (GARBER, ALAN)Sep 25, 2001 - Apr 30, 2007
NIH/FIC
China-US Health and Aging Research Program
Role: Principal Investigator

R13HS010956     (GARBER, ALAN M)May 1, 2001 - Apr 30, 2002
AHRQ
MEDICAL NECESSITY DECISION MAKING IN MANAGED CARE
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Freeman JV, Hutton DW, Barnes GD, Zhu RP, Owens DK, Garber AM, Go AS, Hlatky MA, Heidenreich PA, Wang PJ, Al-Ahmad A, Turakhia MP. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL. Circ Arrhythm Electrophysiol. 2016 Jun; 9(6). PMID: 27307517; PMCID: PMC4911813 [Available on 06/01/17].
  2. Detsky AS, Garber AM. Uber's Message for Health Care. N Engl J Med. 2016 Mar 03; 374(9):806-9. PMID: 26962900.
    View in: PubMed
  3. Khazeni N, Hutton DW, Collins CI, Garber AM, Owens DK. Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study. Ann Intern Med. 2014 May 20; 160(10):684-94. PMID: 24842415; PMCID: PMC4053659.
  4. Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL. Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial". Circulation. 2014 Apr 22; 129(16):e460-1. PMID: 24753557.
    View in: PubMed
  5. Kazi DS, Garber AM, Shah RU, Dudley RA, Mell MW, Rhee C, Moshkevich S, Boothroyd DB, Owens DK, Hlatky MA. Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome. Ann Intern Med. 2014 Feb 18; 160(4):221-32. PMID: 24727840.
    View in: PubMed
  6. Newhouse JP, Garber AM. Geographic differences in US health care spending--reply. JAMA. 2014 Feb 12; 311(6):624-5. PMID: 24519309.
    View in: PubMed
  7. Newhouse JP, Garber AM. Geographic variation in health care spending in the United States: insights from an Institute of Medicine report. JAMA. 2013 Sep 25; 310(12):1227-8. PMID: 24008265.
    View in: PubMed
  8. Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation. 2013 Aug 20; 128(8):785-94. PMID: 23857320; PMCID: PMC3816149.
  9. Simons CT, Cipriano LE, Shah RU, Garber AM, Owens DK, Hlatky MA. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):419-28. PMID: 23838104.
    View in: PubMed
  10. Eibner C, Goldman DP, Sullivan J, Garber AM. Three large-scale changes to the Medicare program could curb its costs but also reduce enrollment. Health Aff (Millwood). 2013 May; 32(5):891-9. PMID: 23650322; PMCID: PMC3886857.
  11. Erickson KF, Japa S, Owens DK, Chertow GM, Garber AM, Goldhaber-Fiebert JD. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol. 2013 Mar 26; 61(12):1250-8. PMID: 23500327; PMCID: PMC3688058.
  12. Newhouse JP, Garber AM. Geographic variation in Medicare services. N Engl J Med. 2013 Apr 18; 368(16):1465-8. PMID: 23520983.
    View in: PubMed
  13. Plutzky J, Garber A, Falahati A, Toft AD, Poulter NR. Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis. Can J Diabetes. 2009; 33(3):209-10. PMID: 25998594.
    View in: PubMed
  14. Perlroth DJ, Bhattacharya J, Goldman DP, Garber AM. An economic analysis of conservative management versus active treatment for men with localized prostate cancer. J Natl Cancer Inst Monogr. 2012 Dec; 2012(45):250-7. PMID: 23271781; PMCID: PMC3540871.
  15. Park KT, Tsai R, Perez F, Cipriano LE, Bass D, Garber AM. Cost-effectiveness of early colectomy with ileal pouch-anal anastamosis versus standard medical therapy in severe ulcerative colitis. Ann Surg. 2012 Jul; 256(1):117-24. PMID: 22270693.
    View in: PubMed
  16. Garber AM. How the Patient-Centered Outcomes Research Institute can best influence real-world health care decision making. Health Aff (Millwood). 2011 Dec; 30(12):2243-51. PMID: 22147851.
    View in: PubMed
  17. Park KT, Perez F, Tsai R, Honkanen A, Bass D, Garber A. Cost-effectiveness analysis of adjunct VSL#3 therapy versus standard medical therapy in pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr. 2011 Nov; 53(5):489-96. PMID: 21694634.
    View in: PubMed
  18. Turan B, Goldstein MK, Garber AM, Carstensen LL. Knowing loved ones' end-of-life health care wishes: attachment security predicts caregivers' accuracy. Health Psychol. 2011 Nov; 30(6):814-8. PMID: 22081941; PMCID: PMC3228368.
  19. Ioannidis JP, Garber AM. Individualized cost-effectiveness analysis. PLoS Med. 2011 Jul; 8(7):e1001058. PMID: 21765810; PMCID: PMC3134464.
  20. Elshaug AG, Garber AM. How CER could pay for itself--insights from vertebral fracture treatments. N Engl J Med. 2011 Apr 14; 364(15):1390-3. PMID: 21488762.
    View in: PubMed
  21. Garber A, Henry RR, Ratner R, Hale P, Chang CT, Bode B. Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes. Diabetes Obes Metab. 2011 Apr; 13(4):348-56. PMID: 21205128; PMCID: PMC3084519.
  22. Chang SL, Cipriano LE, Harshman LC, Garber AM, Chung BI. Cost-effectiveness analysis of nephron sparing options for the management of small renal masses. J Urol. 2011 May; 185(5):1591-7. PMID: 21419445.
    View in: PubMed
  23. Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011 Jan 04; 154(1):1-11. PMID: 21041570.
    View in: PubMed
  24. Garber AM, Sox HC. The role of costs in comparative effectiveness research. Health Aff (Millwood). 2010 Oct; 29(10):1805-11. PMID: 20921479.
    View in: PubMed
  25. Bode BW, Testa MA, Magwire M, Hale PM, Hammer M, Blonde L, Garber A. Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes. Diabetes Obes Metab. 2010 Jul; 12(7):604-12. PMID: 20590735; PMCID: PMC2901519.
  26. Lee CI, Tsai EB, Sigal BM, Plevritis SK, Garber AM, Rubin GD. Incidental extracardiac findings at coronary CT: clinical and economic impact. AJR Am J Roentgenol. 2010 Jun; 194(6):1531-8. PMID: 20489093; PMCID: PMC4827619.
  27. Garber AM. Modernizing device regulation. N Engl J Med. 2010 Apr 01; 362(13):1161-3. PMID: 20335575.
    View in: PubMed
  28. Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM. Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med. 2010 Apr 20; 152(8):481-7, W170-3. PMID: 20194225.
    View in: PubMed
  29. Mikels JA, Löckenhoff CE, Maglio SJ, Goldstein MK, Garber A, Carstensen LL. Following your heart or your head: focusing on emotions versus information differentially influences the decisions of younger and older adults. J Exp Psychol Appl. 2010 Mar; 16(1):87-95. PMID: 20350046; PMCID: PMC3919140.
  30. Perlroth DJ, Glass RJ, Davey VJ, Cannon D, Garber AM, Owens DK. Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States. Clin Infect Dis. 2010 Jan 15; 50(2):165-74. PMID: 20021259.
    View in: PubMed
  31. Perlroth DJ, Goldman DP, Garber AM. The potential impact of comparative effectiveness research on U.S. health care expenditures. Demography. 2010; 47 Suppl:S173-90. PMID: 21302424.
    View in: PubMed
  32. Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK. Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med. 2009 Dec 15; 151(12):829-39. PMID: 20008759; PMCID: PMC3250217.
  33. Khazeni N, Hutton DW, Garber AM, Owens DK. Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Ann Intern Med. 2009 Dec 15; 151(12):840-53. PMID: 20008760; PMCID: PMC3428215.
  34. Xu R, Das AK, Garber AM. Unsupervised method for extracting machine understandable medical knowledge from a large free text collection. AMIA Annu Symp Proc. 2009 Nov 14; 2009:709-13. PMID: 20351945; PMCID: PMC2815389.
  35. Levesque BG, Cipriano LE, Chang SL, Lee KK, Owens DK, Garber AM. Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease. Clin Gastroenterol Hepatol. 2010 Mar; 8(3):261-7, 267.e1-4. PMID: 19896559.
    View in: PubMed
  36. Garber AM, Hlatky MA. The confirmatory trial in comparative-effectiveness research. N Engl J Med. 2009 Oct 08; 361(15):1498-9. PMID: 19812407.
    View in: PubMed
  37. Davis LB, Champion SJ, Fair SO, Baker VL, Garber AM. A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis. Fertil Steril. 2010 Apr; 93(6):1793-804. PMID: 19439290.
    View in: PubMed
  38. Garber AM, Tunis SR. Does comparative-effectiveness research threaten personalized medicine? N Engl J Med. 2009 May 07; 360(19):1925-7. PMID: 19420360.
    View in: PubMed
  39. Garber AM. An uncertain future for cardiovascular drug development? N Engl J Med. 2009 Mar 19; 360(12):1169-71. PMID: 19297568.
    View in: PubMed
  40. Arrow K, Auerbach A, Bertko J, Brownlee S, Casalino LP, Cooper J, Crosson FJ, Enthoven A, Falcone E, Feldman RC, Fuchs VR, Garber AM, Gold MR, Goldman D, Hadfield GK, Hall MA, Horwitz RI, Hooven M, Jacobson PD, Jost TS, Kotlikoff LJ, Levin J, Levine S, Levy R, Linscott K, Luft HS, Mashal R, McFadden D, Mechanic D, Meltzer D, Newhouse JP, Noll RG, Pietzsch JB, Pizzo P, Reischauer RD, Rosenbaum S, Sage W, Schaeffer LD, Sheen E, Silber BM, Skinner J, Shortell SM, Thier SO, Tunis S, Wulsin L, Yock P, Nun GB, Bryan S, Luxenburg O, van de Ven WP. Toward a 21st-century health care system: recommendations for health care reform. Ann Intern Med. 2009 Apr 07; 150(7):493-5. PMID: 19258550.
    View in: PubMed
  41. Xu R, Supekar K, Morgan A, Das A, Garber A. Unsupervised method for automatic construction of a disease dictionary from a large free text collection. AMIA Annu Symp Proc. 2008 Nov 06; 820-4. PMID: 18999169; PMCID: PMC2656087.
  42. Desai AA, Baras J, Berk BB, Nakajima A, Garber AM, Owens D, Chertow GM. Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis. Arch Intern Med. 2008 Sep 08; 168(16):1761-7. PMID: 18779463.
    View in: PubMed
  43. Sims T, Holmes TH, Bravata DM, Garber AM, Nelson LM, Goldstein MK. Simple counts of ADL dependencies do not adequately reflect older adults' preferences toward states of functional impairment. J Clin Epidemiol. 2008 Dec; 61(12):1261-70. PMID: 18722749; PMCID: PMC2596888.
  44. Moayeri SE, Lee HC, Lathi RB, Westphal LM, Milki AA, Garber AM. Laparoscopy in women with unexplained infertility: a cost-effectiveness analysis. Fertil Steril. 2009 Aug; 92(2):471-80. PMID: 18722609.
    View in: PubMed
  45. Garber AM. Is having more preapproval data the best way to assure drug safety? Health Aff (Millwood). 2008 Sep-Oct; 27(5):w371-3. PMID: 18682442.
    View in: PubMed
  46. Garber AM. A menu without prices. Ann Intern Med. 2008 Jun 17; 148(12):964-6. PMID: 18483127.
    View in: PubMed
  47. Garber AM. Commentary: the impact of Medicare coverage policies on health care utilization. Health Serv Res. 2008 Aug; 43(4):1302-7. PMID: 18479412; PMCID: PMC2517266.
  48. Garber AM, Phelps CE. Future costs and the future of cost-effectiveness analysis. J Health Econ. 2008 Jul; 27(4):819-21. PMID: 18539348; PMCID: PMC2574706.
  49. Liu H, Bravata DM, Olkin I, Friedlander A, Liu V, Roberts B, Bendavid E, Saynina O, Salpeter SR, Garber AM, Hoffman AR. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med. 2008 May 20; 148(10):747-58. PMID: 18347346.
    View in: PubMed
  50. Garber AM, Skinner J. Is American health care uniquely inefficient? J Econ Perspect. 2008; 22(4):27-50. PMID: 19305645.
    View in: PubMed
  51. Garber A, Goldman DP, Jena AB. The promise of health care cost containment. Health Aff (Millwood). 2007 Nov-Dec; 26(6):1545-7. PMID: 17978370.
    View in: PubMed
  52. Garber AM, McClellan MB. Satisfaction guaranteed--"payment by results" for biologic agents. N Engl J Med. 2007 Oct 18; 357(16):1575-7. PMID: 17942870.
    View in: PubMed
  53. Emanuel EJ, Fuchs VR, Garber AM. Essential elements of a technology and outcomes assessment initiative. JAMA. 2007 Sep 19; 298(11):1323-5. PMID: 17878424.
    View in: PubMed
  54. Desai AA, Garber AM, Chertow GM. Rise of pay for performance: implications for care of people with chronic kidney disease. Clin J Am Soc Nephrol. 2007 Sep; 2(5):1087-95. PMID: 17702735.
    View in: PubMed
  55. Barnato AE, Chang CC, Saynina O, Garber AM. Influence of race on inpatient treatment intensity at the end of life. J Gen Intern Med. 2007 Mar; 22(3):338-45. PMID: 17356965; PMCID: PMC1824769.
  56. Kurian AW, Thompson RN, Gaw AF, Arai S, Ortiz R, Garber AM. A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer. J Clin Oncol. 2007 Feb 20; 25(6):634-41. PMID: 17308268.
    View in: PubMed
  57. Shetty K, Garber A. B type natriuretic peptide testing was more cost effective than conventional diagnosis in patients with acute dyspnoea. Evid Based Med. 2007 Feb; 12(1):28. PMID: 17264276.
    View in: PubMed
  58. Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, Hoffman AR. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007 Jan 16; 146(2):104-15. PMID: 17227934.
    View in: PubMed
  59. Xu R, Garten Y, Supekar KS, Das AK, Altman RB, Garber AM. Extracting subject demographic information from abstracts of randomized clinical trial reports. Stud Health Technol Inform. 2007; 129(Pt 1):550-4. PMID: 17911777.
    View in: PubMed
  60. Ray JA, Valentine WJ, Roze S, Nicklasson L, Cobden D, Raskin P, Garber A, Palmer AJ. Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US. Diabetes Obes Metab. 2007 Jan; 9(1):103-13. PMID: 17199725.
    View in: PubMed
  61. Garber AM. The price of growth in the medical-device industry. N Engl J Med. 2006 Jul 27; 355(4):337-9. PMID: 16870911.
    View in: PubMed
  62. Liu H, Michaud K, Nayak S, Karpf DB, Owens DK, Garber AM. The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. Arch Intern Med. 2006 Jun 12; 166(11):1209-17. PMID: 16772249.
    View in: PubMed
  63. Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, Garber AM. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA. 2006 May 24; 295(20):2374-84. PMID: 16720823.
    View in: PubMed
  64. Garber AM. To use technology better. Health Aff (Millwood). 2006 Mar-Apr; 25(2):w51-3. PMID: 16464903.
    View in: PubMed
  65. Phibbs CS, Holty JE, Goldstein MK, Garber AM, Wang Y, Feussner JR, Cohen HJ. The effect of geriatrics evaluation and management on nursing home use and health care costs: results from a randomized trial. Med Care. 2006 Jan; 44(1):91-5. PMID: 16365618.
    View in: PubMed
  66. Xu R, Supekar K, Huang Y, Das A, Garber A. Combining text classification and Hidden Markov Modeling techniques for categorizing sentences in randomized clinical trial abstracts. AMIA Annu Symp Proc. 2006; 824-8. PMID: 17238456; PMCID: PMC1839538.
  67. Fowler RA, Sanders GD, Bravata DM, Nouri B, Gastwirth JM, Peterson D, Broker AG, Garber AM, Owens DK. Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax. Ann Intern Med. 2005 Apr 19; 142(8):601-10. PMID: 15838066.
    View in: PubMed
  68. Groeneveld PW, Laufer SB, Garber AM. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989-2000. Med Care. 2005 Apr; 43(4):320-9. PMID: 15778635.
    View in: PubMed
  69. Bravata DM, Nelson LM, Garber AM, Goldstein MK. Invariance and inconsistency in utility ratings. Med Decis Making. 2005 Mar-Apr; 25(2):158-67. PMID: 15800300.
    View in: PubMed
  70. Groeneveld PW, Heidenreich PA, Garber AM. Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J Am Coll Cardiol. 2005 Jan 04; 45(1):72-8. PMID: 15629377.
    View in: PubMed
  71. Garber AM. Evidence-based guidelines as a foundation for performance incentives. Health Aff (Millwood). 2005 Jan-Feb; 24(1):174-9. PMID: 15647228.
    View in: PubMed
  72. Sims TL, Garber AM, Miller DE, Mahlow PT, Bravata DM, Goldstein MK. Multimedia quality of life assessment: advances with FLAIR. AMIA Annu Symp Proc. 2005; 694-8. PMID: 16779129; PMCID: PMC1560717.
  73. Goldman DP, Shang B, Bhattacharya J, Garber AM, Hurd M, Joyce GF, Lakdawalla DN, Panis C, Shekelle PG. Consequences of health trends and medical innovation for the future elderly. Health Aff (Millwood). 2005; 24 Suppl 2:W5R5-17. PMID: 16186147.
    View in: PubMed
  74. Yoo BK, Bhattacharya J, McDonald KM, Garber AM. Impacts of informal caregiver availability on long-term care expenditures in OECD countries. Health Serv Res. 2004 Dec; 39(6 Pt 2):1971-92. PMID: 15544640; PMCID: PMC1361108.
  75. Huang AJ, Gemperli MP, Bergthold L, Singer SS, Garber A. Health plans' coverage determinations for technology-based interventions: the case of electrical bone growth stimulation. Am J Manag Care. 2004 Dec; 10(12):957-62. PMID: 15617371.
    View in: PubMed
  76. Garber AM, Sox HC. The U.S. physician workforce: serious questions raised, answers needed. Ann Intern Med. 2004 Nov 02; 141(9):732-4. PMID: 15520433.
    View in: PubMed
  77. Garber AM. Corporate treatment for the ills of academic medicine. N Engl J Med. 2004 Oct 14; 351(16):1601-3. PMID: 15483277.
    View in: PubMed
  78. Barnato AE, McClellan MB, Kagay CR, Garber AM. Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life. Health Serv Res. 2004 Apr; 39(2):363-75. PMID: 15032959; PMCID: PMC1361012.
  79. Buntin MB, Garber AM, McClellan M, Newhouse JP. The costs of decedents in the Medicare program: implications for payments to Medicare + Choice plans. Health Serv Res. 2004 Feb; 39(1):111-30. PMID: 14965080; PMCID: PMC1360997.
  80. Garber AM. Cost-effectiveness and evidence evaluation as criteria for coverage policy. Health Aff (Millwood). 2004 Jan-Jun; Suppl Web Exclusives:W4-284-96. PMID: 15451997.
    View in: PubMed
  81. Yock CA, Boothroyd DB, Owens DK, Garber AM, Hlatky MA. Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. Am J Med. 2003 Oct 01; 115(5):382-9. PMID: 14553874.
    View in: PubMed
  82. Fowler RA, Hill-Popper M, Stasinos J, Petrou C, Sanders GD, Garber AM. Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis. J Crit Care. 2003 Sep; 18(3):181-91; discussion 191-4. PMID: 14595571.
    View in: PubMed
  83. Groeneveld PW, Heidenreich PA, Garber AM. Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation. 2003 Jul 22; 108(3):286-91. PMID: 12835222.
    View in: PubMed
  84. Barnato AE, Garber AM. Performance of the RAND appropriateness criteria. Med Decis Making. 2003 Mar-Apr; 23(2):177-9. PMID: 12693880.
    View in: PubMed
  85. Haberland CA, Benitz WE, Sanders GD, Pietzsch JB, Yamada S, Nguyen L, Garber AM. Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics. 2002 Sep; 110(3):471-80. PMID: 12205247.
    View in: PubMed
  86. McDonald KM, Hlatky MA, Saynina O, Geppert J, Garber AM, McClellan MB. Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995. Am Heart J. 2002 Sep; 144(3):413-21. PMID: 12228777.
    View in: PubMed
  87. Hlatky MA, Saynina O, McDonald KM, Garber AM, McClellan MB. Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995. Am Heart J. 2002 Sep; 144(3):397-403. PMID: 12228775.
    View in: PubMed
  88. Garber AM, Mulrow C, Sox HC. Articles on diagnostic tests: a new series and an invitation to authors. Ann Intern Med. 2002 Aug 20; 137(4):288-9. PMID: 12186520.
    View in: PubMed
  89. Grundy SM, Garber A, Goldberg R, Havas S, Holman R, Lamendola C, Howard WJ, Savage P, Sowers J, Vega GL. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors. Circulation. 2002 May 07; 105(18):e153-8. PMID: 11994266.
    View in: PubMed
  90. Shortliffe EH, Garber AM. Training synergies between medical informatics and health services research: successes and challenges. J Am Med Inform Assoc. 2002 Mar-Apr; 9(2):133-9. PMID: 11861628; PMCID: PMC344570.
  91. Goldstein MK, Miller DE, Davies S, Garber AM. Quality of life assessment software for computer-inexperienced older adults: multimedia utility elicitation for activities of daily living. Proc AMIA Symp. 2002; 295-9. PMID: 12463834; PMCID: PMC2244139.
  92. Groeneveld PW, Kwong JL, Liu Y, Rodriguez AJ, Jones MP, Sanders GD, Garber AM. Cost-effectiveness of automated external defibrillators on airlines. JAMA. 2001 Sep 26; 286(12):1482-9. PMID: 11572741.
    View in: PubMed
  93. Garber AM. Evidence-based coverage policy. Health Aff (Millwood). 2001 Sep-Oct; 20(5):62-82. PMID: 11558722.
    View in: PubMed
  94. Hagen MD, Garber AM, Goldie SJ, Lafata JE, Mandelblatt J, Meltzer D, Neumann P, Siegel JE, Sox HC, Tsevat J. Does cost-effectiveness analysis make a difference? Lessons from Pap smears. Symposium. Med Decis Making. 2001 Jul-Aug; 21(4):307-23. PMID: 11475387.
    View in: PubMed
  95. Sawaya GF, Brown AD, Washington AE, Garber AM. Clinical practice. Current approaches to cervical-cancer screening. N Engl J Med. 2001 May 24; 344(21):1603-7. PMID: 11372013.
    View in: PubMed
  96. Bayoumi AM, Brown AD, Garber AM. Cost-effectiveness of androgen suppression therapies in advanced prostate cancer. J Natl Cancer Inst. 2000 Nov 01; 92(21):1731-9. PMID: 11058616.
    View in: PubMed
  97. Garber AM. Using cost-effectiveness analysis to target cholesterol reduction. Ann Intern Med. 2000 May 16; 132(10):833-5. PMID: 10819708.
    View in: PubMed
  98. Newman TB, Garber AM. Cholesterol screening in children and adolescents. Pediatrics. 2000 Mar; 105(3 Pt 1):637-8. PMID: 10699121.
    View in: PubMed
  99. Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease. Am J Gastroenterol. 2000 Feb; 95(2):395-407. PMID: 10685741.
    View in: PubMed
  100. Brown AI, Garber AM. A concise review of the cost-effectiveness of coronary heart disease prevention. Med Clin North Am. 2000 Jan; 84(1):279-97, xi. PMID: 10685140.
    View in: PubMed
  101. Garber AM. Realistic rigor in cost-effectiveness methods. Med Decis Making. 1999 Oct-Dec; 19(4):378-9; discussion 383-4. PMID: 10520673.
    View in: PubMed
  102. Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med. 1999 May 18; 130(10):800-9. PMID: 10366369.
    View in: PubMed
  103. Gould MK, Dembitzer AD, Sanders GD, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med. 1999 May 18; 130(10):789-99. PMID: 10366368.
    View in: PubMed
  104. Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med. 1999 May 04; 130(9):719-28. PMID: 10357690.
    View in: PubMed
  105. Seidenfeld J, Samson DJ, Aronson N, Albertson PC, Bayoumi AM, Bennett C, Brown A, Garber A, Gere M, Hasselblad V, Wilt T, Ziegler K. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. Evid Rep Technol Assess (Summ). 1999 May; (4):i-x, 1-246, I1-36, passim. PMID: 11098244; PMCID: PMC4781296.
  106. Brown AD, Garber AM. Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing. JAMA. 1999 Jan 27; 281(4):347-53. PMID: 9929088.
    View in: PubMed
  107. Chen S, Shaheen A, Garber A. Cost-effectiveness and cost-benefit analysis of using methotrexate vs Goeckerman therapy for psoriasis. A pilot study. Arch Dermatol. 1998 Dec; 134(12):1602-8. PMID: 9875201.
    View in: PubMed
  108. Brown AD, Garber AM. Cost effectiveness of coronary heart disease prevention strategies in adults. Pharmacoeconomics. 1998 Jul; 14(1):27-48. PMID: 10182193.
    View in: PubMed
  109. Krakow D, Reinker K, Powell B, Cantor R, Priore MA, Garber A, Lachman RS, Rimoin DL, Cohn DH. Localization of a multiple synostoses-syndrome disease gene to chromosome 17q21-22. Am J Hum Genet. 1998 Jul; 63(1):120-4. PMID: 9634519; PMCID: PMC1377242.
  110. Garber AM. Making the most of Pap testing. JAMA. 1998 Jan 21; 279(3):240-1. PMID: 9438749.
    View in: PubMed
  111. Lenert LA, Cher DJ, Goldstein MK, Bergen MR, Garber A. The effect of search procedures on utility elicitations. Med Decis Making. 1998 Jan-Mar; 18(1):76-83. PMID: 9456212.
    View in: PubMed
  112. Weinstein MC, Siegel JE, Garber AM, Lipscomb J, Luce BR, Manning WG, Torrance GW. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Econ. 1997 Sep-Oct; 6(5):505-10. PMID: 9353651.
    View in: PubMed
  113. Lenert LA, Morss S, Goldstein MK, Bergen MR, Faustman WO, Garber AM. Measurement of the validity of utility elicitations performed by computerized interview. Med Care. 1997 Sep; 35(9):915-20. PMID: 9298080.
    View in: PubMed
  114. Hornberger JC, Garber AM, Jeffery JR. Mortality, hospital admissions, and medical costs of end-stage renal disease in the United States and Manitoba, Canada. Med Care. 1997 Jul; 35(7):686-700. PMID: 9219496.
    View in: PubMed
  115. Garber AM, Browner WS. Cholesterol screening guidelines. Consensus, evidence, and common sense. Circulation. 1997 Mar 18; 95(6):1642-5. PMID: 9118535.
    View in: PubMed
  116. Lee TT, Solomon NA, Heidenreich PA, Oehlert J, Garber AM. Cost-effectiveness of screening for carotid stenosis in asymptomatic persons. Ann Intern Med. 1997 Mar 01; 126(5):337-46. PMID: 9054277.
    View in: PubMed
  117. Clarke AE, Goldstein MK, Michelson D, Garber AM, Lenert LA. The effect of assessment method and respondent population on utilities elicited for Gaucher disease. Qual Life Res. 1997 Mar; 6(2):169-84. PMID: 9161117.
    View in: PubMed
  118. Garber AM. Cholesterol screening should be targeted. Am J Med. 1997 Feb 17; 102(2A):26-30. PMID: 9217583.
    View in: PubMed
  119. Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997 Feb; 16(1):1-31. PMID: 10167341.
    View in: PubMed
  120. Flowers CR, Garber AM, Bergen MR, Lenert LA. Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems. Proc AMIA Annu Fall Symp. 1997; 223-7. PMID: 9357621; PMCID: PMC2233361.
  121. Garber AM, Romer PM. Evaluating the federal role in financing health-related research. Proc Natl Acad Sci U S A. 1996 Nov 12; 93(23):12717-24. PMID: 8917484; PMCID: PMC34127.
  122. Barnett PG, Garber AM. The cost of VA-sponsored research. Acad Med. 1996 Oct; 71(10):1074-8. PMID: 9177641.
    View in: PubMed
  123. Owens DK, Holodniy M, Garber AM, Scott J, Sonnad S, Moses L, Kinosian B, Schwartz JS. Polymerase chain reaction for the diagnosis of HIV infection in adults. A meta-analysis with recommendations for clinical practice and study design. Ann Intern Med. 1996 May 01; 124(9):803-15. PMID: 8610949.
    View in: PubMed
  124. Goldman L, Garber AM, Grover SA, Hlatky MA. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 6. Cost effectiveness of assessment and management of risk factors. J Am Coll Cardiol. 1996 Apr; 27(5):1020-30. PMID: 8609317.
    View in: PubMed
  125. Garber AM, Browner WS, Hulley SB. Cholesterol screening in asymptomatic adults, revisited. Part 2. Ann Intern Med. 1996 Mar 01; 124(5):518-31. PMID: 8602715.
    View in: PubMed
  126. Garber AM. Cost-effectiveness analysis as a measure of value. Tecnologica. 1996 Jan; 1, 3-6, 9-10. PMID: 10170483.
    View in: PubMed
  127. Newman TB, Garber AM, Holtzman NA, Hulley SB. Problems with the report of the Expert Panel on blood cholesterol levels in children and adolescents. Arch Pediatr Adolesc Med. 1995 Mar; 149(3):241-7. PMID: 7858682.
    View in: PubMed
  128. Goldstein MK, Clarke AE, Michelson D, Garber AM, Bergen MR, Lenert LA. Developing and testing a multimedia presentation of a health-state description. Med Decis Making. 1994 Oct-Dec; 14(4):336-44. PMID: 7528868.
    View in: PubMed
  129. Weinstein MJ, Garber AM, Fryback DG. Disease Prevention Research at NIH: An Agenda for All. Workshop J: Prevention strategies, economic realities, and identification of prevention research needs. Prev Med. 1994 Sep; 23(5):571-2. PMID: 7845914.
    View in: PubMed
  130. Beutler E, Garber AM. Alglucerase for Gaucher's disease: dose, costs and benefits. Pharmacoeconomics. 1994 Jun; 5(6):453-9. PMID: 10147261.
    View in: PubMed
  131. Garber A. The effect of intensive treatment of diabetes mellitus. N Engl J Med. 1994 Mar 03; 330(9):641-2. PMID: 8302353.
    View in: PubMed
  132. Garber AM. Can technology assessment control health spending? Health Aff (Millwood). 1994; 13(3):115-26. PMID: 7927142.
    View in: PubMed
  133. Hulley SB, Newman TB, Grady D, Garber AM, Baron RB, Browner WS. Should we be measuring blood cholesterol levels in young adults? JAMA. 1993 Mar 17; 269(11):1416-9. PMID: 8441219.
    View in: PubMed
  134. Hornberger JC, Garber AM, Chernew ME. Is high-flux dialysis cost-effective? Int J Technol Assess Health Care. 1993; 9(1):85-96. PMID: 8423119.
    View in: PubMed
  135. Garber AM. No price too high? N Engl J Med. 1992 Dec 03; 327(23):1676-8. PMID: 1435903.
    View in: PubMed
  136. Hornberger JC, Chernew M, Petersen J, Garber AM. A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol. 1992 Dec; 3(6):1227-37. PMID: 1477318.
    View in: PubMed
  137. Goldman DP, Clarke AE, Garber AM. Creating the costliest orphan. The Orphan Drug Act in the development of Ceredase. Int J Technol Assess Health Care. 1992; 8(4):583-97. PMID: 1464480.
    View in: PubMed
  138. Garber AM, Littenberg B, Sox HC, Wagner JL, Gluck M. Costs and health consequences of cholesterol screening for asymptomatic older Americans. Arch Intern Med. 1991 Jun; 151(6):1089-95. PMID: 1904212.
    View in: PubMed
  139. Garber AM, Fenerty JP. Costs and benefits of prenatal screening for cystic fibrosis. Med Care. 1991 May; 29(5):473-89. PMID: 1673488.
    View in: PubMed
  140. Garber AM, Wagner JL. Practice guidelines and cholesterol policy. Health Aff (Millwood). 1991; 10(2):52-66. PMID: 1885147.
    View in: PubMed
  141. Fuchs VR, Garber AM. The new technology assessment. N Engl J Med. 1990 Sep 06; 323(10):673-7. PMID: 2385272.
    View in: PubMed
  142. Littenberg B, Garber AM, Sox HC. Screening for hypertension. Ann Intern Med. 1990 Feb 01; 112(3):192-202. PMID: 2136982.
    View in: PubMed
  143. Garber AM. Where to draw the line against cholesterol. Ann Intern Med. 1989 Oct 15; 111(8):625-7. PMID: 2802415.
    View in: PubMed
  144. Sox HC, Garber AM, Littenberg B. The resting electrocardiogram as a screening test. A clinical analysis. Ann Intern Med. 1989 Sep 15; 111(6):489-502. PMID: 2528311.
    View in: PubMed
  145. Garber AM. A discrete-time model of the acquisition of antibiotic-resistant infections in hospitalized patients. Biometrics. 1989 Sep; 45(3):797-816. PMID: 2790122.
    View in: PubMed
  146. Garber AM, Sox HC, Littenberg B. Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level. Ann Intern Med. 1989 Apr 15; 110(8):622-39. PMID: 2648923.
    View in: PubMed
  147. Sox HC, Littenberg B, Garber AM. The role of exercise testing in screening for coronary artery disease. Ann Intern Med. 1989 Mar 15; 110(6):456-69. PMID: 2493211.
    View in: PubMed
  148. Garber AM. Cost-containment and financing the long-term care of the elderly. J Am Geriatr Soc. 1988 Apr; 36(4):355-61. PMID: 3127455.
    View in: PubMed
  149. Garber AM. Antibiotic exposure and resistance in mixed bacterial populations. Theor Popul Biol. 1987 Dec; 32(3):326-46. PMID: 3433231.
    View in: PubMed
  150. Fenerty JP, Garber AM. Costs and benefits of prenatal screening for cystic fibrosis. JAMA. 1987 Feb 03; 261(5):786. PMID: 11652528.
    View in: PubMed
  151. Garber AM, Fuchs VR, Silverman JF. Case mix, costs, and outcomes. Differences between faculty and community services in a university hospital. N Engl J Med. 1984 May 10; 310(19):1231-7. PMID: 6424018.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu. FAS faculty should contact the Office for Scholarly Communication (oschulmail.harvard.edu) for general questions about Profiles. For data questions, please contact Raelyn Lincoln (raelyn_lincolnharvard.edu) from the FAS Division of Science; Jennifer Shephard (jmshephfas.harvard.edu) from the FAS Division of Social Science; or Alexander Parker (afparkerfas.harvard.edu) from the FAS Division of Arts and Humanities. SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Garber's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_